These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1377283

  • 1. Expression of the neu oncogene under the transcriptional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells.
    Hayes C, Kelly D, Murayama S, Komiyama A, Suzuki K, Popko B.
    J Neurosci Res; 1992 Jan; 31(1):175-87. PubMed ID: 1377283
    [Abstract] [Full Text] [Related]

  • 2. Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system.
    Baron-Van Evercooren A, Jensen NA, Wyss MT, Cuzin F, Rassoulzadegan M, Brucher JM, Baron H.
    Lab Invest; 1992 Jan; 66(1):39-53. PubMed ID: 1309929
    [Abstract] [Full Text] [Related]

  • 3. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
    Weissenberger J, Steinbach JP, Malin G, Spada S, Rülicke T, Aguzzi A.
    Oncogene; 1997 May 01; 14(17):2005-13. PubMed ID: 9160879
    [Abstract] [Full Text] [Related]

  • 4. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT, Wu C, Fecenko-Tacka K.
    J Neurosci Res; 2004 Jul 01; 77(1):15-25. PubMed ID: 15197735
    [Abstract] [Full Text] [Related]

  • 5. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC.
    Cancer Res; 2002 Oct 01; 62(19):5551-8. PubMed ID: 12359767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The specificity of the myelin basic protein gene promoter studied in transgenic mice.
    Asipu A, Mellor AL, Blair GE.
    Biochem Biophys Res Commun; 2001 Nov 09; 288(4):809-18. PubMed ID: 11688980
    [Abstract] [Full Text] [Related]

  • 9. Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus.
    Chen H, McCarty DM, Bruce AT, Suzuki K, Suzuki K.
    Gene Ther; 1998 Jan 09; 5(1):50-8. PubMed ID: 9536264
    [Abstract] [Full Text] [Related]

  • 10. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Hede SM, Hansson I, Afink GB, Eriksson A, Nazarenko I, Andrae J, Genove G, Westermark B, Nistér M.
    Glia; 2009 Aug 15; 57(11):1143-53. PubMed ID: 19115382
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the human MBP promoter in primary cultures of oligodendrocytes: positive and negative cis-acting elements in the proximal MBP promoter mediate oligodendrocyte-specific expression of MBP.
    Wrabetz L, Shumas S, Grinspan J, Feltri ML, Bozyczko D, McMorris FA, Pleasure D, Kamholz J.
    J Neurosci Res; 1993 Nov 01; 36(4):455-71. PubMed ID: 7505842
    [Abstract] [Full Text] [Related]

  • 12. Cellular expression of an HMGCR promoter-CAT fusion gene in transgenic mouse brain: evidence for a developmental regulation in oligodendrocytes.
    Duhamel-Clerin E, Villarroya H, Mehtali M, Lapie P, Besnard F, Gumpel M, Lachapelle F.
    Glia; 1994 May 01; 11(1):35-46. PubMed ID: 8070893
    [Abstract] [Full Text] [Related]

  • 13. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes.
    Turnley AM, Morahan G, Okano H, Bernard O, Mikoshiba K, Allison J, Bartlett PF, Miller JF.
    Nature; 1991 Oct 10; 353(6344):566-9. PubMed ID: 1717849
    [Abstract] [Full Text] [Related]

  • 14. Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas.
    Golfinos JG, Norman SA, Coons SW, Norman RA, Ballecer C, Scheck AC.
    Clin Cancer Res; 1997 May 10; 3(5):799-804. PubMed ID: 9815752
    [Abstract] [Full Text] [Related]

  • 15. Intracellular distribution of transgenic bacterial beta-galactosidase in central nervous system neurons and neuroglia.
    Friedrich VL, Holstein GR, Li X, Gow A, Kelley KA, Lazzarini RA.
    J Neurosci Res; 1993 Sep 01; 36(1):88-98. PubMed ID: 8230324
    [Abstract] [Full Text] [Related]

  • 16. Distinct hypomyelinated phenotypes in MBP-SV40 large T transgenic mice.
    Jensen NA, Smith GM, Shine HD, Garvey JS, Hood L.
    J Neurosci Res; 1993 Feb 15; 34(3):257-64. PubMed ID: 7681114
    [Abstract] [Full Text] [Related]

  • 17. Sox10 acts as a tissue-specific transcription factor enhancing activation of the myelin basic protein gene promoter by p27Kip1 and Sp1.
    Wei Q, Miskimins WK, Miskimins R.
    J Neurosci Res; 2004 Dec 15; 78(6):796-802. PubMed ID: 15523643
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA, Orian JM, Gonzales MF, Tan SS, Alexander B, Mikoshiba K, Kaye AH.
    Cancer Res; 1995 Oct 01; 55(19):4302-10. PubMed ID: 7671240
    [Abstract] [Full Text] [Related]

  • 20. Brain tumors in S100beta-v-erbB transgenic rats.
    Ohgaki H, Kita D, Favereaux A, Huang H, Homma T, Dessen P, Weiss WA, Kleihues P, Heppner FL.
    J Neuropathol Exp Neurol; 2006 Dec 01; 65(12):1111-7. PubMed ID: 17146284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.